Structural proteomics. Market indicators

Nature Reviews Drug Discovery

Volumn 1, Issue 3, 2002, Pages 175-176

  Renfrey, Siân ^a   Featherstone, James ^a  

^a Wood Mackenzie   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; PROTEOME; AMLODIPINE BESYLATE; AMOXICILLIN PLUS CLAVULANIC ACID; AMPRENAVIR; ATORVASTATIN; CELECOXIB; CONJUGATED ESTROGEN; ENALAPRIL MALEATE; FLUOXETINE; G PROTEIN COUPLED RECEPTOR; LANSOPRAZOLE; LORATADINE; LOSARTAN POTASSIUM; MEMBRANE PROTEIN; METFORMIN; NELFINAVIR; OLANZAPINE; OMEPRAZOLE; PAROXETINE; PRAVASTATIN; PROTEINASE INHIBITOR; RECOMBINANT ERYTHROPOIETIN; ROFECOXIB; SERTRALINE; SIMVASTATIN; ZANAMIVIR;

ARTICLE; CHEMISTRY; GENOME; HUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; X RAY CRYSTALLOGRAPHY; BIOINFORMATICS; BIOTECHNOLOGY; COMMERCIAL PHENOMENA; COMPUTER PROGRAM; DRUG APPROVAL; DRUG DESIGN; DRUG INDUSTRY; DRUG MARKETING; DRUG RESEARCH; DRUG TARGETING; ENZYME INHIBITION; GENE SEQUENCE; MASS SPECTROMETRY; NOTE; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN DATABASE; PROTEOMICS; ROBOTICS; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

CRYSTALLOGRAPHY, X-RAY; GENOME, HUMAN; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; PROTEINS; PROTEOME;

EID: 0036490720     PISSN: 14741776     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrd766     Document Type: Note

References (4)

1. Blundell, T. L., Jhoti, H. #38; Abell, C. High-throughput crystallography for lead discovery in drug design. Nature Rev. Drug Discov. 1, 45-54 (2002).
2. Opella, S., Ma, C. #38; Marassi, F. M. Nuclear magnetic resonance of membrane-associated peptides and proteins. Methods Enzymol. 339, 285-313 (2001).
3. Russell, R. B. #38; Eggleston, D. S. New roles for structure in biology and drug discovery. Nature Struct. Biol. 7 (Suppl.), 928-930 (2000).
4. Nicholson, J. K., Connelly, J., Lindon, J. C. #38; Holmes, E. Metabonomics: a platform for studying drug toxicity and gene function. Nature Rev. Drug Discov. 1, 153-161 (2002).